Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness

Beactica Therapeutics AB, a Swedish precision medicine company, today announced that it, together with leading glioblastoma researchers at KU Leuven, has been awarded a EUR 2.5 million grant by the ...

Beactica Therapeutics AB: Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness

Beactica Therapeutics AB, a Swedish precision medicine company, today announced that it, together with leading glioblastoma researchers at KU Leuven ...
Goldseiten

Arizona Sonoran and Nuton Terminate Option to Joint Venture on the Cactus Project

Arizona Sonoran Copper Company Inc. today announces that ASCU and Nuton LLC , a Rio Tinto Venture, have mutually agreed to ...